Advertising Disclaimer
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersen, J. M.
Right arrow Articles by Weinberg, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersen, J. M.
Right arrow Articles by Weinberg, W. A.
Related Collections
Right arrow Gastrointestinal Tract
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 100 No. 6 December 1997, pp. 977-981

Effective Prophylactic Therapy for Cyclic Vomiting Syndrome in Children Using Amitriptyline or Cyproheptadine

Received Dec 16, 1996; accepted May 12, 1997.

John M. Andersen*, Kathryn S. Sugerman*, Jennifer R. Lockhart*, and Warren A. WeinbergDagger

From the Departments of * Pediatrics and Dagger  Neurology, University of Texas Southwestern Medical Center and Children's Medical Center, Dallas, Texas.

Objective.  To evaluate our experience using the antimigraine prophylactic drugs, amitriptyline and cyproheptadine, for the prophylactic management of cyclic vomiting syndrome (CVS) in children.

Methods and Patients.  Twenty-seven patients (16 males) ranging in age from 2 to 16 years at diagnosis, fulfilling the diagnostic criteria for CVS and treated prophylactically with either amitriptyline (22) or/and cyproheptadine (6) were identified through retrospective chart review. Individual patient data were corroborated by the attending physician and/or interviews with patients and families. Minimum follow-up time before entry into the study group was 5 months. Patients were stratified according to three treatment outcomes: 1) complete response---no attacks, 2) partial response---50% or greater reduction in frequency of attacks, and 3) no response---less than 50% decrease in frequency of attacks.

Results.  Of the 22 patients treated with amitriptyline, 16 (73%) had a complete response while 4 (18%) had a partial response. Of the 6 patients treated with cyproheptadine, 4 (66%) had a complete response and 1 (17%) had a partial response. Thus, 91% of the amitriptyline group and 83% of the cyproheptadine group had at least a partial response to therapy. No patients experienced significant side effects to either medication.

Conclusion.  The antimigraine prophylactic drugs, amitriptyline and cyproheptadine, represent effective prophylactic agents for the management of CVS in the vast majority of patients fulfilling the diagnostic criteria for this syndrome.

Key words: cyclic vomiting syndrome, migraine, amitriptyline, cyproheptadine.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Nutr Clin PractHome page
M. A. McOmber and R. J. Shulman
Pediatric Functional Gastrointestinal Disorders
Nutr Clin Pract, June 1, 2008; 23(3): 268 - 274.
[Abstract] [Full Text] [PDF]

Home page
 cfpHome page
S. Chow and R. D. Goldman
Treating children's cyclic vomiting
Can Fam Physician, March 1, 2007; 53(3): 417 - 419.
[Abstract] [Full Text] [PDF]

Home page
 CephalalgiaHome page
G Boccia, E Del Giudice, A. Crisanti, C Strisciuglio, A Romano, and A Staiano
Functional Gastrointestinal Disorders in Migrainous Children: Efficacy of Flunarizine
Cephalalgia, October 1, 2006; 26(10): 1214 - 1219.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
R. G. Boles, A. L.R. Powers, and K. Adams
Cyclic Vomiting Syndrome Plus
J Child Neurol, March 1, 2006; 21(3): 182 - 189.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
R. A. Brumback
Warren A. Weinberg (1934--2002)
J Child Neurol, December 1, 2002; 17(12): 916 - 922.
[PDF]

Home page
 Arch. Dis. Child.Home page
F Dignan, D N K Symon, I AbuArafeh, and G Russell
The prognosis of cyclical vomiting syndrome
Arch. Dis. Child., January 1, 2001; 84(1): 55 - 57.
[Abstract] [Full Text]

Home page
 PediatricsHome page
N. M. Watemberg, K. S. Roth, F. K. Alehan, and C. E. Epstein
Central Anticholinergic Syndrome on Therapeutic Doses of Cyproheptadine
Pediatrics, January 1, 1999; 103(1): 158 - 160.
[Full Text] [PDF]

Home page
 JWatch GeneralHome page
TREATING CYCLIC VOMITING SYNDROME IN CHILDREN
Journal Watch (General), December 16, 1997; 1997(1216): 5 - 5.
[Full Text]